Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

[Cyclooxigenase-1 gene polymorphism and aspirin resistance].

Bondar' TN, Kravchenko NA.

Tsitol Genet. 2012 Jul-Aug;46(4):66-72. Review. Russian.

PMID:
23074965
2.

Aspirin resistance: does it exist and is it an important clinical problem?

Eikelboom J.

Clin Adv Hematol Oncol. 2006 Apr;4(4):268-70. Review. No abstract available.

PMID:
16728937
3.

Drug insight: aspirin resistance--fact or fashion?

Patrono C, Rocca B.

Nat Clin Pract Cardiovasc Med. 2007 Jan;4(1):42-50. Review.

PMID:
17180149
4.
5.

[Aspirin resistance theory].

Porosińska A, Pierzchała K.

Neurol Neurochir Pol. 2006 Jul-Aug;40(4):313-9. Review. Polish.

PMID:
16967353
6.

Genetic variation in cyclooxygenase 1: effects on response to aspirin.

Halushka MK, Walker LP, Halushka PV.

Clin Pharmacol Ther. 2003 Jan;73(1):122-30.

PMID:
12545150
7.

Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.

Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS.

Thromb Haemost. 2008 Jul;100(1):83-9. doi: 10.1160/TH07-10-0590.

PMID:
18612542
8.

Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.

Kobzar G, Mardla V, Samel N.

Platelets. 2011;22(5):338-44. doi: 10.3109/09537104.2010.535931. Epub 2011 May 11.

PMID:
21557683
9.

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.

Circulation. 2007 Jun 26;115(25):3156-64. Epub 2007 Jun 11.

10.

Laboratory detection of 'aspirin resistance': what test should we use (if any)?

Cattaneo M.

Eur Heart J. 2007 Jul;28(14):1673-5. Epub 2007 Jun 22. No abstract available.

PMID:
17586540
11.

Testing aspirin resistance using the Platelet Function Analyzer-100: some methodological caveats and considerations.

Madsen EH, Schmidt EB, Gehr N, Johannesen NL, Kristensen SR.

J Thromb Haemost. 2008 Feb;6(2):386-8. Epub 2007 Nov 23. No abstract available.

12.

Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.

Momary KM, Shapiro NL, Brace LD, Shord SS, Grossi E, Viana MA, Helgason CM, Nutescu EA, Cavallari LH.

Cerebrovasc Dis. 2009;27(6):585-93. doi: 10.1159/000214223. Epub 2009 Apr 24.

PMID:
19390185
13.

Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.

Pettinella C, Romano M, Stuppia L, Santilli F, Liani R, Davì G.

Thromb Haemost. 2009 Apr;101(4):687-90.

PMID:
19350112
14.

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.

Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T.

Circulation. 2003 Aug 5;108(5):542-7. Epub 2003 Jul 21.

15.
16.
17.

Aspirin resistance and atherothrombotic disease.

Maree AO, Jneid H, Fitzgerald DJ.

J Am Coll Cardiol. 2006 Aug 15;48(4):846-7; author reply 847. Epub 2006 Jul 24. No abstract available.

18.

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.

Maree AO, Fitzgerald DJ.

Circulation. 2007 Apr 24;115(16):2196-207. Review. No abstract available.

19.
20.

Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease.

Fan L, Cao J, Liu L, Li X, Hu G, Hu Y, Zhu B.

Gerontology. 2013;59(2):122-31. doi: 10.1159/000342489. Epub 2012 Sep 28.

PMID:
23038044

Supplemental Content

Support Center